SAPHNELO Trademark

Trademark Overview

On Friday, March 13, 2020, a trademark application was filed for SAPHNELO with the United States Patent and Trademark Office. The USPTO has given the SAPHNELO trademark a serial number of 88833575. The federal status of this trademark filing is REGISTERED as of Tuesday, March 22, 2022. This trademark is owned by AstraZeneca AB. The SAPHNELO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of immune-mediated inflammatory diseases and disorders
saphnelo

General Information

Serial Number88833575
Word MarkSAPHNELO
Filing DateFriday, March 13, 2020
Status700 - REGISTERED
Status DateTuesday, March 22, 2022
Registration Number6680167
Registration DateTuesday, March 22, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 20, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of immune-mediated inflammatory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 19, 2020
Primary Code005
First Use Anywhere DateSaturday, July 31, 2021
First Use In Commerce DateSaturday, July 31, 2021

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Tuesday, March 22, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, February 17, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, February 16, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, December 17, 2021STATEMENT OF USE PROCESSING COMPLETE
Monday, November 22, 2021USE AMENDMENT FILED
Friday, December 17, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 22, 2021TEAS STATEMENT OF USE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 15, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 20, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 31, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 17, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 17, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 17, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 15, 2021ASSIGNED TO LIE
Monday, March 8, 2021ASSIGNED TO LIE
Friday, December 4, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 5, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 5, 2020NON-FINAL ACTION E-MAILED
Friday, June 5, 2020NON-FINAL ACTION WRITTEN
Friday, June 5, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 5, 2020NON-FINAL ACTION E-MAILED
Friday, June 5, 2020NON-FINAL ACTION WRITTEN
Friday, June 5, 2020ASSIGNED TO EXAMINER
Thursday, March 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 17, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

saphnelo inflammatory diseases disorders mediated immune preparations substances treatment pharmaceutical